COVID-19 Case Series at UnityPoint Health St. Luke’s Hospital in Cedar Rapids, IA
HCQ+AZ early in the epidemic had a fairly good success rate with few complications, 86% of HCQ patients survived and 92% of HCQ+AZ patients. Patients not receiving either had 93% survival but were not considered comparable because the treated groups were significantly more ill (100% hypoxic at admission vs. 59%) and this study does not adjust for the differences.
Transition from an early intubation strategy to aggressive utilization of high flow nasal cannula and noninvasive ventilation (i.e, BiPAP) was successful in freeing up ICU resources.
This study is excluded in the after exclusion results of meta
analysis:
excessive unadjusted differences between groups.
risk of death, 70.0% higher, RR 1.70, p = 0.69, treatment 4 of 33 (12.1%), control 3 of 42 (7.1%).
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
McGrail et al., 19 Jul 2020, retrospective, USA, preprint, 2 authors.
Abstract: medRxiv preprint doi: https://doi.org/10.1101/2020.07.17.20156521; this version posted July 19, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .
COVID-19 Case Series at UnityPoint Health St. Luke’s Hospital in Cedar Rapids, IA
Dianna Edwards, MD - Unity Point St. Luke’s Hospital, Daniel McGrail, MD - His Hands Free Clinic
7/17/2020
Abstract
A retrospective, descriptive study of all patients tested for SARS-CoV2 on admission for illness to a
community hospital in Iowa from 3/21/20 thru 6/14/20 consisted of evaluation as to demographics,
presentation and hospital course. Ninety-one patients were SARS-CoV2 PCR+ with 63% being male and
a median age of 60. Cardiovascular disease was a significant comorbidity in the PCR+ group. Fever,
cough, dyspnea, nausea, emesis, diarrhea, headache and myalgias were significantly more common in
that group, as was an elevated CRP, LDH, serum ferritin and transaminases. Overall survival of the
COVID-19 patients was 88%, 77% in the critically ill, 59% of those mechanically ventilated and 33% of
those requiring new dialysis. Survival was 93% in those not receiving any antivirals. Survival of those
treated with hydroxychloroquine-azithromycin was 92%, compared to 86% of those treated with
hydroxychloroquine alone. The latter two groups were significantly more ill than the untreated group.
A transition from an early intubation strategy to aggressive utilization of high flow nasal cannula and
noninvasive ventilation(i.e BiPAP) was successful in freeing up ICU resources.
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit